This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992;18(4):424-33.

doi: 10.1055/s-2007-1002580.

Cancer cell procoagulants and their role in malignant disease

S G Gordon¹

Affiliations

PMID: 1470929
DOI: 10.1055/s-2007-1002580

Review

Cancer cell procoagulants and their role in malignant disease

S G Gordon. Semin Thromb Hemost. 1992.

. 1992;18(4):424-33.

doi: 10.1055/s-2007-1002580.

Author

S G Gordon¹

Affiliation

¹ Department of Pathology and Medical Oncology, University of Colorado Health Sciences Center, Denver 80262.

PMID: 1470929
DOI: 10.1055/s-2007-1002580

No abstract available

PubMed Disclaimer

Similar articles

Cancer cell procoagulants and their implications.
Gordon SG. Gordon SG. Hematol Oncol Clin North Am. 1992 Dec;6(6):1359-74. Hematol Oncol Clin North Am. 1992. PMID: 1452517 Review.
Macrophage procoagulants.
Edwards RL, Rickles FR. Edwards RL, et al. Prog Hemost Thromb. 1984;7:183-209. Prog Hemost Thromb. 1984. PMID: 6397766 Review.
Overview of the postulated mechanisms linking cancer and thrombosis.
ten Cate H, Falanga A. ten Cate H, et al. Pathophysiol Haemost Thromb. 2008;36(3-4):122-30. doi: 10.1159/000175150. Epub 2009 Jan 27. Pathophysiol Haemost Thromb. 2008. PMID: 19176985 Review.
The role of platelets in blood coagulation. Possible significance for hemostasis.
Walsh PN. Walsh PN. Medicina (B Aires). 1973 Mar-Apr;33(2):163-80. Medicina (B Aires). 1973. PMID: 4720173 No abstract available.
[Coagulation factors and blood platelets. (Presence and location of factor VIII and of fibrinogen in normal human platelets and in patients with coagulation disorders, using an immunofluorescence technic)].
Fabris F, Betterle C, Casonato A, De Marco L, Girolami A. Fabris F, et al. Ric Clin Lab. 1979;9(2 Suppl):51-63. Ric Clin Lab. 1979. PMID: 395621 Review. Italian. No abstract available.

See all similar articles

Cited by

Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer.
Kirwan CC, Descamps T, Castle J. Kirwan CC, et al. Clin Transl Oncol. 2020 Jun;22(6):870-877. doi: 10.1007/s12094-019-02197-6. Epub 2019 Aug 31. Clin Transl Oncol. 2020. PMID: 31473984 Free PMC article.
The hemostatic system and angiogenesis in malignancy.
Wojtukiewicz MZ, Sierko E, Klement P, Rak J. Wojtukiewicz MZ, et al. Neoplasia. 2001 Sep-Oct;3(5):371-84. doi: 10.1038/sj.neo.7900184. Neoplasia. 2001. PMID: 11687948 Free PMC article. Review.
The cancer stem cell: evidence for its origin as an injured autoreactive T cell.
Grandics P. Grandics P. Mol Cancer. 2006 Feb 14;5:6. doi: 10.1186/1476-4598-5-6. Mol Cancer. 2006. PMID: 16478542 Free PMC article. Review.
The hypercoagulable state of malignancy: pathogenesis and current debate.
Caine GJ, Stonelake PS, Lip GY, Kehoe ST. Caine GJ, et al. Neoplasia. 2002 Nov-Dec;4(6):465-73. doi: 10.1038/sj.neo.7900263. Neoplasia. 2002. PMID: 12407439 Free PMC article. Review.
Clinical significance of the ratio between the alpha 2 plasmin inhibitor-plasmin complex and the thrombin-antithrombin complex in advanced non-small cell lung cancer.
Masago K, Fujita S, Mio T, Togashi Y, Kim YH, Hatachi Y, Fukuhara A, Irisa K, Sakamori Y, Mishima M. Masago K, et al. Med Oncol. 2011 Mar;28(1):351-6. doi: 10.1007/s12032-010-9454-y. Epub 2010 Mar 19. Med Oncol. 2011. PMID: 20300980

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Georg Thieme Verlag Stuttgart, New York
Other Literature Sources
- The Lens - Patent Citations Database